TABLE 3.
Adverse event | No. (%) of subjects with indicated adverse event at a nemonoxacin dosage ofa: |
||
---|---|---|---|
250 mg (n = 12) | 500 mg (n = 12) | 750 mg (n = 11) | |
Injection site reaction | 3 (25) | 4 (33) | 7 (64) |
Erythematous rash | 0 (0) | 1 (8) | 2 (18) |
Total | 3 (25) | 5 (42) | 9 (82) |
The infusion rate for each group was 5.56 mg/min.